Next generation biomanufacturing technologies are needed to increase global access to biologic drugs and bolster biosecurity. The integrated process development group creates pipelines and processes designed to achieve more productive processes, at lower costs on accelerated development timelines. Process development is conducted on our custom-developed InSCyT platform which enables integrated continuous biomanufacturing from perfusion fermentation through drug formulation. The team continues to work with the Bill and Melinda Gates foundation to enable rapid development of low-cost subunit vaccines.
